Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A
Condition: Fanconi Anemia Complementation Group A Intervention: Biological: RP-L102 Sponsor: Rocket Pharmaceuticals Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2019 Category: Research Source Type: clinical trials